Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,980 | -1,360 | -540 | -140 | 240 |
| Depreciation Amortization | 130 | 90 | 40 | 190 | 140 |
| Other Working Capital | 120 | 70 | 6 | 2,100 | 520 |
| Other Operating Activity | 720 | 900 | 484 | -2,240 | -330 |
| Operating Cash Flow | $-1,010 | $-300 | $-10 | $-90 | $570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -7 | 0 | -170 | -190 |
| Investing Cash Flow | $-7 | $-7 | $0 | $-170 | $-190 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| Exchange Rate Effect | -6 | -8 | -6 | 70 | 50 |
| Beginning Cash Position | 1,290 | 1,290 | 1,290 | 1,480 | 1,480 |
| End Cash Position | 260 | 970 | 1,270 | 1,290 | 1,920 |
| Net Cash Flow | $-1,020 | $-310 | $-10 | $190 | $430 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,010 | -300 | -10 | -90 | 570 |
| Free Cash Flow | -1,010 | -300 | -10 | -90 | 570 |